Ritonavir Withdrawn Phase 1 Trials for Pulmonary Arterial Hypertension (PAH) Basic Science

IndicationsStatusPurposePhase
WithdrawnBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT01251848Drug Interaction Between Ritonavir And Sitaxsentan